Inhaled Iloprost as an Adjunct to Inhaled Nitric Oxide in Pediatric Critical Care Patients
Status:
Withdrawn
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether inhaled iloprost is safe and effective in
pediatric patients with pulmonary hypertension who are sick in the intensive care unit.